PCI-assigned patients, just 0.5% developed CS in the group randomized 2 hours from
symptom onset. A major focus of public health campaigns is the very early recognition and …

Aims Few studies describe recent changes in the prevalence, management, and outcomes
of cardiogenic shock (CS) patients complicating acute myocardial infarction (AMI) in the era …

Objectives The purpose of this study was to examine the temporal trends in demographics,
clinical characteristics, management strategies, and in-hospital outcomes in patients with …

Aim The historical evolution of incidence and outcome of cardiogenic shock (CS) in acute
myocardial infarction (AMI) patients is debated. This study compared outcomes in AMI …

and management remains challenging despite advances in therapeutic options. CS is
caused by severe impairment of myocardial performance that results in diminished cardiac …

Background: Long-term trends of the incidence and outcome of cardiogenic shock (CS)
patients are scarce. We analyze for the first time trends in the incidence and outcome of CS …

Background: Few studies describe recent changes in the incidence, treatment, and
outcomes of cardiogenic shock. Objective: To examine temporal trends in the incidence …

Background—Cardiogenic shock is a deadly complication of an acute myocardial infarction
(MI). We sought to characterize differences in patient features, treatments, and outcomes of …

INTRODUCTION: Despite advances in the management of patients with an acute coronary
syndrome (ACS), cardiogenic shock (CS) remains the leading cause of death in these …

Aims Despite advances in the management of patients with acute coronary syndrome (ACS),
cardiogenic shock (CS) remains the leading cause of death in these patients. We describe …